SoVarGen Co., Ltd.
PrivateLast Round
VC Round
Feb 11, 2026
Est. Valuation
$83.01M
Total Funding Raised
$40.89M
Company Overview
SoVarGen Co., Ltd. is a biotechnology company that develops antisense oligonucleotide and mRNA therapies for the treatment of intractable central nervous system diseases caused by brain somatic mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SoVarGen Co., Ltd. Comparables
Compare SoVarGen Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neumirna Therapeutics | 82% | |
| Vico Therapeutics | 79% | |
| Deep Genomics | 74% |
SoVarGen Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 11, 2026 | ||||
| VC Round | Jul 1, 2025 | ||||
| Series B | Dec 3, 2020 | ||||
| Series A | Sep 1, 2018 |
SoVarGen Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Premier Partners | VC Round |
| HB Investment | Series B |
| Korea Development Bank | VC Round |
| Forward Equity Partners | Series B |
| Atinum Investment | VC Round, Series B, Series A |
SoVarGen Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SoVarGen Co., Ltd.'s valuation, stock price, and market status.
Is SoVarGen Co., Ltd. a public or private company?
SoVarGen Co., Ltd. is a private company.
What is the current stock price of SoVarGen Co., Ltd.?
SoVarGen Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is SoVarGen Co., Ltd. worth (valuation)?
SoVarGen Co., Ltd.'s valuation is estimated at $83.0M based on funding round data.
Can I buy SoVarGen Co., Ltd. stock?
SoVarGen Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SoVarGen Co., Ltd.'s last funding round?
SoVarGen Co., Ltd.'s most recent funding round was VC Round on February 11, 2026.
Who are the main investors in SoVarGen Co., Ltd.?
Key investors in SoVarGen Co., Ltd. include Premier Partners, HB Investment, Korea Development Bank, Forward Equity Partners, Atinum Investment.
Will SoVarGen Co., Ltd. IPO soon?
No public IPO plans have been announced for SoVarGen Co., Ltd..
How can I track SoVarGen Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SoVarGen Co., Ltd.'s secondary market activity and sign up for updates.